Multiple sclerosis (MS) is an inflammatory, autoimmune disease that affects the ability of the brain and spinal cord nerve cells to communicate resulting in physical and cognitive disability. It is the most common cause of neurological disability in early and middle adulthood. Over 400,000 people in the US are diagnosed with MS. While therapies exist, none significantly change the long-term prognosis for sufferers.
To identify biomarkers or “signals” that mark the onset and progression of the disease, 1,000 MS patients over the age of 18 are being recruited for a study led by Simon G. Gregory, PhD, associate professor at the Duke Center for Human Genetics and director of the Genomics Laboratory at the David H. Murdock Research Institute.
There are no geographic boundaries for enrollment. For information or to enroll, e-mail Leah Boulter Bouk, study coordinator, or call 704-250-5861.
For more information about the MS study and others sponsored by the MURDOCK Study, visit www.murdock-study.org.